Kidney failure is one of the costliest health conditions for the American health system. The imperative for better value in healthcare, coupled with new challenges driven by COVID-19, has amplified the need to reimagine how hemodialysis is delivered across a variety of settings. This will be a pivotal year for Quanta as we build our US presence and bring our next generation hemodialysis system to a community ripe with need.